Clinical Trials

Clinical Trials in: Acute Liver Failure

1. A Multicenter Therapy Trial for Acute Liver Failure

   • Eligibility - Fulminant liver failure of any cause
   • Treatment - This is an NIH observational study
   • Principal Investigator - Steven Huy-Han, M.D.
   • Contact - Val Peacock, RN (310) 794-6067

2. A Phase IV, 2x2 Factorial, Double-Blind Design of 24 Versus 48 Weeks and 90 Versus 180 mcg Doses of Pegylated Interferon Alfa-2A 40 KD (Peg-IFN, RO 25-8310) in Adult Patients with HBEAG Positive Chronic Hepatitis B"

   • Eligibility - Chronic hepatits B patients, HBe(+), elevated ALT levels
   • Treatment - Pegylated interferon -alfa-2a
   • Principal Investigator - Steven Huy-Han, M.D.
   • Contact - Val Peacock, RN - (310) 794-6067

For More Information on clinical trials at UCLA:  UCLA Clinical Trials